News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Quanterix Issued Key Patent for Simoa™ Technology



8/7/2012 10:09:54 AM

LEXINGTON, Mass.--(BUSINESS WIRE)--Quanterix Corporation, developer of the Single Molecule Array (Simoa) technology, announced today that it had been issued a US Patent for ultra-sensitive detection of molecules. The patent issue marks another milestone for Quanterix and highlights the achievements of the company’s scientific team for developing a truly novel approach to single molecule immunoassays. The ability to trap individual molecules in arrays of femtoliter wells and to count each one in a digital fashion allows measurement of proteins or nucleic acids at sub-femtomolar concentrations with great precision. This revolutionary approach enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening up new applications that address significant unmet needs in life science research, companion diagnostics, specialty in-vitro diagnostics, blood screening, food testing and biothreat detection.

Read at BioSpace.com


comments powered by Disqus
Quanterix
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES